Journal Article Summary
The article investigates the bioequivalence of a fixed-dose combination (FDC) tablet containing macitentan and tadalafil, two medications used to treat pulmonary arterial hypertension (PAH). The study is particularly relevant due to the COVID-19 pandemic, which imposed restrictions on clinical trials, necessitating an adaptive study design. Establishing bioequivalence is crucial because it ensures that the FDC tablet can be used interchangeably with the individual components without compromising efficacy or safety, thereby simplifying treatment regimens for patients.
In this Phase 1 study, 62 healthy adults participated in a randomized, crossover design to compare the pharmacokinetics of the FDC tablet against individual tablets of macitentan and tadalafil. The study was divided into two parts: one assessing bioequivalence under fasted conditions and the other evaluating the effect of food on the FDC. The results indicated that the FDC tablet was bioequivalent to the individual components for most pharmacokinetic parameters, although the maximum plasma concentration (C max) for both drugs was slightly outside the bioequivalence limits when taken with food. Overall, the FDC was well tolerated, with no significant safety concerns reported.
Despite the study's strengths, there are limitations, including a small sample size due to pandemic-related disruptions and the fact that one participant experienced a serious adverse event. Patients should be aware that while the FDC can be taken with or without food, the slight increase in C max under fed conditions may not be clinically significant. It is advisable for patients to discuss any concerns or questions about this medication with their healthcare provider, especially regarding its use in conjunction with other treatments for PAH.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Csonka Dénes, Fishman Vladislav, Natarajan Jaya, Stieltjes Hans, Armas Danielle, Dishy Victor, Perez Ruixo Juan Jose. Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic. Pharmacology Research & Perspectives 2021. DOI: 10.1002/prp2.846. PMID: 34624174. PMCID: PMC8500343.
Featured Pill Pals Product
Tadalafil 5 MG Tablets --- Generic for Cialis --- Ajanta Pharma
Tadalafil 5 MG Tablets — Generic for Cialis — Ajanta Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
